PuSH - Publikationsserver des Helmholtz Zentrums München

Kolahian, S.* ; Fernandez, I.E. ; Eickelberg, O. ; Hartl, D.*

Immune mechanisms in pulmonary fibrosis.

Am. J. Respir. Cell Mol. Biol. 55, 309-322 (2016)
Verlagsversion Postprint DOI PMC
Open Access Green
Pulmonary fibrosis, particularly idiopathic pulmonary fibrosis, represents a chronic and progressive disease with high mortality and limited therapeutic options. Excessive deposition of extracellular matrix proteins results in fibrotic remodeling, alveolar destruction and irreversible loss of lung function. Both innate and adaptive immune mechanisms contribute to fibrogenesis at several cellular and non-cellular levels. Here, we summarize and discuss the role of immune cells (T cells, neutrophils, macrophages and fibrocytes) and soluble mediators (cytokines and chemokines) involved in pulmonary fibrosis, pointing towards novel immune-based therapeutic strategies in the field.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Korrespondenzautor
Schlagwörter T Cells ; Fibrosis ; Immunity ; Lung ; Neutrophils; Epithelial-mesenchymal Transition; Growth-factor-beta; Muc5b Promoter Polymorphism; Human Lung Fibroblasts; Regulatory T-cells; Gamma-delta T; Bronchoalveolar Lavage Fluid; Tyrosine Kinase Inhibitor; Versus-host-disease; Tgf-beta
ISSN (print) / ISBN 1044-1549
e-ISSN 1535-4989
Zeitschrift American Journal of Respiratory Cell and Molecular Biology
Quellenangaben Band: 55, Heft: 3, Seiten: 309-322 Artikelnummer: , Supplement: ,
Verlag American Thoracic Society
Verlagsort New York
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Lung Health and Immunity (LHI)
Institute of Lung Biology (LHI)